172 related articles for article (PubMed ID: 35160082)
1. Risk of Acute Anterior Uveitis in Ankylosing Spondylitis According to the Type of Tumor Necrosis Factor-Alpha Inhibitor and History of Uveitis: A Nationwide Population-Based Study.
Ahn SM; Kim M; Kim YJ; Lee Y; Kim YG
J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160082
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis.
Lee S; Park YJ; Lee JY
J Korean Med Sci; 2019 Nov; 34(42):e278. PubMed ID: 31674159
[TBL] [Abstract][Full Text] [Related]
3. Comparative risk of incident and recurrent acute anterior uveitis across different biological agents in patients with ankylosing spondylitis.
Kwon OC; Lee HS; Yang J; Park MC
Rheumatology (Oxford); 2024 Jan; ():. PubMed ID: 38243710
[TBL] [Abstract][Full Text] [Related]
4. Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database.
Wendling D; Joshi A; Reilly P; Jalundhwala YJ; Mittal M; Bao Y
Curr Med Res Opin; 2014 Dec; 30(12):2515-21. PubMed ID: 25252590
[TBL] [Abstract][Full Text] [Related]
5. Predictors of extra-articular manifestations in axial spondyloarthritis and their influence on TNF-inhibitor prescribing patterns: results from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis.
Derakhshan MH; Dean L; Jones GT; Siebert S; Gaffney K
RMD Open; 2020 Jul; 6(2):. PubMed ID: 32641447
[TBL] [Abstract][Full Text] [Related]
6. Reduced Occurrence Rate of Acute Anterior Uveitis in Ankylosing Spondylitis Treated with Golimumab - The GO-EASY Study.
van Bentum RE; Heslinga SC; Nurmohamed MT; Gerards AH; Griep EN; Koehorst CBJM; Kok MR; Schilder AM; Verhoef M; van der Horst-Bruinsma IE
J Rheumatol; 2019 Feb; 46(2):153-159. PubMed ID: 30385705
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha inhibitors for ankylosing spondylitis.
Maxwell LJ; Zochling J; Boonen A; Singh JA; Veras MM; Tanjong Ghogomu E; Benkhalti Jandu M; Tugwell P; Wells GA
Cochrane Database Syst Rev; 2015 Apr; (4):CD005468. PubMed ID: 25887212
[TBL] [Abstract][Full Text] [Related]
8. Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art.
Fabiani C; Vitale A; Lopalco G; Iannone F; Frediani B; Cantarini L
Clin Rheumatol; 2016 Nov; 35(11):2631-2638. PubMed ID: 27686662
[TBL] [Abstract][Full Text] [Related]
9. Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy?
Mitulescu TC; Trandafir M; Dimăncescu MG; Ciuluvică RC; Popescu V; Predețeanu D; Istrate S; Voinea LM
Rom J Ophthalmol; 2018; 62(2):114-122. PubMed ID: 30206554
[TBL] [Abstract][Full Text] [Related]
10. The risk factors and incidence of major infectious diseases in patients with ankylosing spondylitis receiving tumor necrosis factor inhibitors.
Koo BS; Lim YC; Lee MY; Jeon JY; Yoo HJ; Oh IS; Shin JY; Kim TH
Mod Rheumatol; 2021 Nov; 31(6):1192-1201. PubMed ID: 33494621
[TBL] [Abstract][Full Text] [Related]
11. The effect of extra-articular manifestations on tumor necrosis factor-α inhibitor treatment duration in patients with ankylosing spondylitis: nationwide data from the Korean College of Rheumatology BIOlogics (KOBIO) registry.
Kim Y; Park S; Kim HS
Clin Rheumatol; 2018 Dec; 37(12):3275-3284. PubMed ID: 30251059
[TBL] [Abstract][Full Text] [Related]
12. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M
J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743
[TBL] [Abstract][Full Text] [Related]
13. Uveitis occurrence in patients with ankylosing spondylitis according to the type of tumour necrosis factor inhibitor: a cohort study of 175 patients.
Choi EY; Lee M; Lee CS
Clin Exp Rheumatol; 2020; 38(6):1132-1137. PubMed ID: 32828140
[TBL] [Abstract][Full Text] [Related]
14. The Risk of Major Adverse Cardiovascular Events in Ankylosing Spondylitis Patients With a History of Acute Anterior Uveitis: A Nationwide, Population Based Cohort Study.
Bai YC; Liu CH; Leong PY; Lai KL; Chen HH; Wei JC
Front Med (Lausanne); 2022; 9():884800. PubMed ID: 35872802
[TBL] [Abstract][Full Text] [Related]
15. Dose Reduction of Tumor Necrosis Factor Inhibitor and its Effect on Medical Costs for Patients with Ankylosing Spondylitis.
Koo BS; Lim YC; Lee MY; Jeon JY; Yoo HJ; Oh IS; Shin JY; Kim TH
Rheumatol Ther; 2021 Mar; 8(1):347-359. PubMed ID: 33420967
[TBL] [Abstract][Full Text] [Related]
16. Acute Anterior Uveitis as a Risk Factor of Ankylosing Spondylitis-A National Population-Based Study.
Yen JC; Hsu CA; Hsiao SH; Hsu MH
Int J Environ Res Public Health; 2017 Jan; 14(1):. PubMed ID: 28124984
[TBL] [Abstract][Full Text] [Related]
17. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
[TBL] [Abstract][Full Text] [Related]
18. Golimumab for the treatment of ankylosing spondylitis: a NICE single technology appraisal.
Armstrong N; Joore M; van Asselt T; Misso K; Manning N; Tomini F; Kleijnen J; Riemsma R
Pharmacoeconomics; 2013 May; 31(5):415-25. PubMed ID: 23580355
[TBL] [Abstract][Full Text] [Related]
19. Do tumor necrosis factor inhibitors cause uveitis? A registry-based study.
Lim LL; Fraunfelder FW; Rosenbaum JT
Arthritis Rheum; 2007 Oct; 56(10):3248-52. PubMed ID: 17907169
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Incidence or Recurrence of Anterior Uveitis in Patients with Ankylosing Spondylitis Treated with Tumor Necrosis Factor Inhibitors.
Kwon HY; Kim YJ; Kim TH; Ahn SJ
J Clin Med; 2024 Feb; 13(3):. PubMed ID: 38337605
[No Abstract] [Full Text] [Related]
[Next] [New Search]
